Standout Papers

Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis 2015 2026 2018 2022 665
  1. Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis (2015)
    Lutz Wollin, Eva Wex et al. European Respiratory Journal

Immediate Impact

3 by Nobel laureates 9 from Science/Nature 65 standout
Sub-graph 1 of 23

Citing Papers

Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis
2025 Standout
Alveolar fibroblast lineage orchestrates lung inflammation and fibrosis
2024 StandoutNature
3 intermediate papers

Works of Eva Wex being referenced

Olodaterol shows anti‐fibrotic efficacy in in vitro and in vivo models of pulmonary fibrosis
2017
Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis
2015 Standout

Author Peers

Author Last Decade Papers Cites
Eva Wex 223 604 20 181 9 863
Hisashi Oku 159 636 19 278 10 1.0k
Banu A. Karimi-Shah 200 572 21 388 5 961
O Nettelbladt 258 338 13 158 16 770
Carmel B. Nanthakumar 92 576 41 228 12 892
Barbara DeLustro 70 388 13 239 9 836
Daryle J. DePianto 101 334 12 413 17 1.0k
Fabienne Prost 85 236 27 179 10 746
K. Zhang 86 408 31 263 8 940
Xiaochuan Xu 76 823 38 296 10 1.1k
Shahriar Shahzeidi 97 565 67 253 14 906

All Works

Loading papers...

Rankless by CCL
2026